ClassID:

92779

C07C233/54 - CPC Classification

Classification description:

Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton

Recent Application in this class:
#1
20260115159
2026-04-30

ALKYLAMIDO COMPOUNDS AND USES THEREOF

#2
20240409498
2024-12-12

PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOF

#3
20240373847
2024-11-14

HERBICIDAL MALONAMIDES

#4
20240184199
2024-06-06

Onium Salt, Resist Composition, And Patterning Process

#5
20240082418
2024-03-14

METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE

#6
20220354809
2022-11-10

Alkylamido Compounds and Uses Thereof

#7
20220350243
2022-11-03

RESIST COMPOSITION AND PATTERN FORMING PROCESS

#8
20220249687
2022-08-11

BIS(2-HALOACETAMIDO)-COMPOUNDS FOR USE AS LINKING AGENTS AND RESULTANT PRODUCTS WHICH COMPRISE ANTIBODIES, HALF-ANTIBODIES AND ANTIBODY FRAGMENTS

#9
20220227720
2022-07-21

DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS

#10
20220226497
2022-07-21

NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE

#11
20220194894
2022-06-23

Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

#12
20210107862
2021-04-15

Methods and compositions for substance use disorder vaccine formulations and uses thereof

#13
20200384121
2020-12-10

Method for producing antibody-drug conjugate

#14
20200383942
2020-12-10

Alkylamido Compounds and Uses Thereof

#15
20200262784
2020-08-20

Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

#16
20200216407
2020-07-09

RETINOID COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATES THEREOF AND APPLICATION THEREOF

#17
20200188340
2020-06-18

Methods of treating hair related conditions

#18
20200148937
2020-05-14

INHIBITING HYDROCARBON HYDRATE AGGLOMERATION

#19
20200115324
2020-04-16

METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF

#20
20190308934
2019-10-10

Prodrugs of Chlorokynurenines

#21
20190269637
2019-09-05

Alkylamido Compounds and Uses Thereof

#22
20190185413
2019-06-20

BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF

#23
20190155155
2019-05-23

Resist composition and patterning process

#24
20190135782
2019-05-09

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

#25
20190092744
2019-03-28

Retinoid compound, preparation method therefor, intermediates thereof and application thereof

#26
20190062277
2019-02-28

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

#27
20190016670
2019-01-17

Trifluoromethoylation of arenes via intramolecular trifluoromethoxy group migration

#28
20180369178
2018-12-27

Methods of treating hair related conditions

#29
20180327351
2018-11-15

PRODRUGS OF CHLOROKYNURENINES

#30
20180297935
2018-10-18

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#31
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

#32
20180215707
2018-08-02

ROR-gamma modulators and uses thereof

#33
20170362166
2017-12-21

β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof

#34
20170351177
2017-12-07

Resist composition and patterning process

#35
20170298008
2017-10-19

Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

#36
20170233370
2017-08-17

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

#37
20170172956
2017-06-22

Alkylamido compounds and uses thereof

#38
20170114070
2017-04-27

INHIBITORS OF THE WNT SIGNALLING PATHWAYS

#39
20170036992
2017-02-09

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#40
20160338927
2016-11-24

Methods of treating hair related conditions

#41
20160263122
2016-09-15

Compounds

#42
20160120838
2016-05-05

Compositions and methods for the treatment of inflammatory bowel disease

#43
20150152461
2015-06-04

Genetically encoded initiator for polymer growth from proteins

#44
20150079035
2015-03-19

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

#45
20150051285
2015-02-19

Alkylamido compounds and uses thereof

#46
20140378541
2014-12-25

Synthetic Epigallocatechin Gallate (EGCG) Analogs

#47
20140316008
2014-10-23

N-phenyl anthranilic acid derivatives and uses thereof

#48
20140303248
2014-10-09

N-benzylaniline derivative and uses thereof

#49
20140249306
2014-09-04

HIV replication inhibitor

#50
20130331446
2013-12-12

3-acyl-ingenols II

#51
20130225588
2013-08-29

Substituted naphthylacetic acids

#52
20130224790
2013-08-29

Chalcone structure fluorescence dye for embryonic stem cell probe

#53
20130158135
2013-06-20

Organogel compositions comprising alkylated aromatic acids

#54
20120316230
2012-12-13

Compounds and their salts specific to the PPAR receptors and the EGF Receptors and their use in the medical field

#55
20120283326
2012-11-08

Anthranilic acid derivatives

#56
20120258996
2012-10-11

Ligands that modulate RAR receptors

#57
20120202756
2012-08-09

USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS

#58
20120165559
2012-06-28

Compounds Having a Physiological Effect

#59
20120101157
2012-04-26

4,5-Diamino-3-Halo-2-Hydroxybenzoic Acid Derivatives and Preparations Thereof

#60
20120090983
2012-04-19

Continuous Method For Acylating Amino Group-Carrying Organic Acids

#61
20120059055
2012-03-08

-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

#62
20120058123
2012-03-08

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

#63
20120053245
2012-03-01

Methods of treating hair related conditions

#64
20120053244
2012-03-01

Alkylamido compounds and uses thereof

#65
20120004228
2012-01-05

Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors

#66
20110311813
2011-12-22

Self-assembled nanostructures

#67
20110288057
2011-11-24

SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS

#68
20110184194
2011-07-28

Surfactant Compositions and Synthesis

#69
20110178108
2011-07-21

Group of amino substituted benzoyl derivatives and their preparation and their use

#70
20110152210
2011-06-23

POLYPHENOL COMPOUNDS FOR INHIBITING PROTEASOME AND USES THEREOF

#71
20110130562
2011-06-02

Surfactant-enabled transition metal-catalyzed chemistry

#72
20110105544
2011-05-05

CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER

#73
20110039852
2011-02-17

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors

#74
20100298360
2010-11-25

SMALL MOLECULE INHIBITORS OF PDZ INTERACTIONS

#75
20100292296
2010-11-18

Ligands that modulate RAR receptors

#76
20100267827
2010-10-21

PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

#77
20100261910
2010-10-14

Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates

#78
20100160346
2010-06-24

NEUROLOGICALLY ACTIVE COMPOUNDS

#79
20100158843
2010-06-24

3-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereof

#80
20100137296
2010-06-03

N-phenyl anthranilic acid derivatives and uses thereof

#81
20100029767
2010-02-04

Anthranilic acid derivatives

#82
20090324540
2009-12-31

Compounds and compositions for delivering active agents

#83
20090227591
2009-09-10

Cyclopentene compounds

#84
20090215780
2009-08-27

Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity

#85
20090197959
2009-08-06

-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors

#86
20090124620
2009-05-14

Plasminogen activator inhibitor-1 inhibitor

#87
20090118357
2009-05-07

Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field

#88
20090118289
2009-05-07

(Biphenyl) carboxylic acids and derivatives thereof

#89
20090105474
2009-04-23

Anthranilic acid derivative or salt thereof

#90
20090062340
2009-03-05

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

#91
20080227684
2008-09-18

Small Molecule Inhibitors of PDZ Interactions

#92
20080213347
2008-09-04

Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof

#93
20080146742
2008-06-19

Functionalized esters, amides or urethanes of perfluorinated alcohols or amines as surface modifiers

#94
20080112899
2008-05-15

Carboxamides and Their Use

#95
20080045483
2008-02-21

Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes

#96
20080015246
2008-01-17

Ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof

#97
20070287840
2007-12-13

Process for preparing telmisartan

#98
20070219394
2007-09-20

Process for the synthesis of N-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids

#99
20070135641
2007-06-14

Synthesis

#100
20070105913
2007-05-10

Alkynyl aryl carboxamides

#101
20070088022
2007-04-19

Tetrahydroquinolines, synthesis thereof, and intermediates thereto

#102
20060235057
2006-10-19

Phenyl compounds

#103
20060223879
2006-10-05

Non-steroidal farnesoid x receptor modulators

#104
20060167000
2006-07-27

8-hydroxy and 8-mercapto quinazolinones

#105
20060166859
2006-07-27

Compounds and compositions for delivering active agents

#106
20060160875
2006-07-20

Matrix metalloproteinase inhibitors

#107
20060128764
2006-06-15

Non-steroidal farnesoid X receptor modulators and methods for the use thereof

#108
20060099159
2006-05-11

Amine, amide, sulphonamide and carbamate derivatives of benzalmalonic salts and photoprotective cosmetic compositions comprised thereof

#109
20060052638
2006-03-09

One-pot reductive acetamidation of aryl nitro compounds

#110
20050272815
2005-12-08

Compounds and compositions for delivering active agents

#111
20050267168
2005-12-01

Pentanoic acid derivatives

#112
20050267167
2005-12-01

Pentanoic acid derivatives

#113
20050261371
2005-11-24

Pentanoic acid derivatives

#114
20050256116
2005-11-17

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

#115
20050239802
2005-10-27

(2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives

#116
20050234131
2005-10-20

Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof

#117
20050187297
2005-08-25

Compounds, methods for their preparation and use thereof

#118
20050186176
2005-08-25

Compounds and compositions for delivering active agents

#119
20050143449
2005-06-30

Non-steroidal farnesoid X receptor modulators and methods for the use thereof

#120
20050113366
2005-05-26

Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses

#121
20050101671
2005-05-12

Compounds and compositions for delivering active agents

#122
20050085662
2005-04-21

Process for the synthesis of N-nacyl-2-amino-4-alkoxy-5-nitrobenzoic acids

#123
20050049416
2005-03-03

Synthesis